AEON Biopharma, Inc. Class A Common Stock — Cash Flow (NYSE:AEON)

Financials

Cash from operating activities -1.49 M-981.43 K-1.87 M-20.29 M-17.31 M -12.04 M Cash from investing activities -276 M401.93 K-306 K—-4 000 — Cash from financing activities 277.99 M150 K40.51 M15.15 M20.3 M 7.83 M Free cash flow -1.49 M-981.43 K-1.87 M-20.29 M-17.31 M -12.04 M

AEON

Financials

News

AEON Biopharma names John Bencich as chief financial officer

Aeon Biopharma stock falls after FDA meeting and debt restructuring

AEON Biopharma completes FDA meeting, shareholders approve transactions

AEON and Daewoong finalize $15 million debt-to-equity exchange deal

Ocado’s robotic future under threat as Kroger looks to Instacart

AEON Biopharma schedules FDA meeting to review botox biosimilar data

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

AEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025